RECRUITING

Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus

Description

The purpose of this study is to evaluate the safety and efficacy of ventricular microdosing of indocyanine green (ICG) in order to assess cerebrospinal fluid (CSF) ventricular dynamics and extracranial CSF outflow using fluorescent Cap-based Transcranial Optical Tomography (fCTOT) and Near-InfraRed Fluorescent (NIRF) imaging and to evaluate inflammation markers of the CSF and to correlate with CSF ventricular dynamics, extracranial outflow into the lymphatics, ventriculomegaly, and patient's clinical outcome in order to understand how inflammation may impact that status of extracranial outflow.

Conditions

Post-hemorrhagic Hydrocephalus (PHH)
Talk to us

Related Conditions:

Post-hemorrhagic Hydrocephalus (PHH)

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to evaluate the safety and efficacy of ventricular microdosing of indocyanine green (ICG) in order to assess cerebrospinal fluid (CSF) ventricular dynamics and extracranial CSF outflow using fluorescent Cap-based Transcranial Optical Tomography (fCTOT) and Near-InfraRed Fluorescent (NIRF) imaging and to evaluate inflammation markers of the CSF and to correlate with CSF ventricular dynamics, extracranial outflow into the lymphatics, ventriculomegaly, and patient's clinical outcome in order to understand how inflammation may impact that status of extracranial outflow.

Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus

Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus

Condition
Post-hemorrhagic Hydrocephalus (PHH)
Intervention / Treatment

-

Contacts and Locations

Houston

The University of Texas Health Science Center at Houston, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Children born premature currently in the NICU with a diagnosis of PHH who have undergone ventricular reservoir placement.
  • * For the first four study subjects, we will attempt for the child to undergo CT cisternography when clinically stable 3-4 weeks after reservoir placement.
  • * Parents who do not consent for procedure on their child
  • * Children who are deemed clinically unstable or unsuitable for imaging by clinical staff as defined by the subject's level of intensive care (e.g. can the subject be repositioned without compromise to the level of care needed or condition)
  • * Children known or suspected to have allergy to iodine or ICG
  • * Children who do not have a subcutaneous reservoir for CSF diversion from the lateral ventricle

Ages Eligible for Study

to 6 Months

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Eva Sevick,

Manish Shah, MD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

2029-01-03